j
u
r
n
l
p
r
e
p
r
f
highlight
cxc
motif
chemokin
novel
chemokin
play
function
role
maintain
homeostasi
distinct
mucos
barrier
express
associ
diseas
progress
well
protect
effect
variou
diseas
includ
pulmonari
system
multifactori
mechanist
properti
could
exploit
therapeut
target
translat
applic
cxc
motif
chemokin
novel
chemokin
play
function
role
maintain
homeostasi
distinct
mucos
barrier
includ
regul
myeloidcel
recruit
angiogenesi
control
microorgan
particularli
produc
along
epithelium
airway
steadi
state
inflammatori
condit
increas
express
associ
diseas
progress
pulmonari
fibrosi
asthma
lunghepat
cancer
thought
play
protect
role
pancreat
cancer
autoimmun
encephalomyel
viral
infect
thu
emerg
evid
point
harm
protect
role
human
health
diseas
therapeut
potenti
translat
applic
review
provid
overview
discoveri
characterist
function
emphas
clinic
potenti
respiratori
disord
mutant
glu
replac
cy
cy
replac
ala
adp
adenosin
diphosph
ampk
activ
protein
kinas
amp
antimicrobi
peptid
apc
antigenpres
cell
bal
bronchioalveolar
lavag
immort
human
bronchial
epitheli
cell
bfgf
basic
fibroblast
growth
factor
camp
cyclic
adenosin
monophosph
cc
motif
chemokin
ligand
cc
motif
chemokin
ligand
cc
motif
chemokin
ligand
cc
motif
chemokin
j
u
r
n
l
p
r
e
p
r
f
ligand
cc
motif
chemokin
ligand
cc
motif
chemokin
ligand
cc
motif
chemokin
ligand
cc
motif
chemokin
receptor
cc
motif
chemokin
receptor
cluster
differenti
cluster
differenti
cluster
differenti
cluster
differenti
cluster
differenti
cxc
motif
chemokin
ligand
cxc
motif
chemokin
ligand
cxc
motif
chemokin
ligand
cxc
motif
chemokin
cxc
motif
chemokin
ligand
cxc
motif
chemokin
ligand
cxc
motif
chemokin
receptor
cxc
motif
chemokin
receptor
cxc
motif
chemokin
receptor
cxc
motif
chemokin
receptor
cxc
motif
chemokin
receptor
da
dalton
dc
dendrit
cell
dl
dexter
colon
cancer
cell
line
dmc
dendrit
cell
monocytelik
protein
eae
experiment
autoimmun
encephalomyel
elr
glutam
acidleucinearginin
triad
extracellular
signalregul
kinas
forkhead
box
gpcr
g
proteincoupl
receptor
gpr
g
proteincoupl
receptor
growthregul
oncogen
gtp
guanosin
triphosph
hacat
human
keratinocyt
cell
line
human
hepatocellular
carcinoma
cell
line
hhc
human
hepatocellular
carcinoma
hmvec
human
microvascular
endotheli
cell
hsv
herp
simplex
viru
huvec
human
umbil
vascular
endotheli
cell
intracellular
adhes
molecul
interferon
gamma
interleukin
interleukin
interleukin
interleukin
interleukin
interleukin
interleukin
ilc
group
innat
lymphoid
cell
ipf
interstiti
pulmonari
fibrosi
jak
janu
kinas
jnk
cjun
ntermin
kinas
antigen
leu
leucin
lp
lipopolysaccharid
mapk
mitogenactiv
protein
kinas
mdsc
myeloidderiv
stem
cell
micro
rna
mrna
j
u
r
n
l
p
r
e
p
r
f
messeng
rna
nhek
normal
human
epiderm
keratinocyt
normal
embryon
mous
fibroblast
cell
line
nsclc
nonsmal
cell
lung
cancer
onpg
nitrophenylbdgalactopyranois
phe
phenylalanin
postn
periostin
ptx
pertussi
toxin
human
hepatocellular
carcinoma
cell
line
spdi
secret
protein
discoveri
initi
spvec
sephranos
vascular
endotheli
cell
stat
signal
transduc
activ
transcript
human
colon
cancer
cell
line
tb
tuberculosi
human
leukemia
monocyt
cell
line
tumor
necrosi
factor
alpha
treg
regulatori
cell
upa
urokinasetyp
plasminogen
activ
upar
urokinasetyp
plasminogen
activ
receptor
utr
untransl
region
vegf
coregul
chemokin
vegfa
vascular
endotheli
growth
factor
respiratori
tract
play
vital
role
respiratori
physiolog
enabl
ga
exchang
alveolarcapillari
membran
airway
continu
contact
airborn
particul
matter
respiratori
epithelium
colon
sever
speci
viru
bacteria
fungi
nonetheless
infect
diseas
progress
prevent
innat
pulmonari
defens
mechan
continu
function
immun
system
necessari
maintain
respiratori
barrier
integr
microb
also
regul
prevent
excess
tissu
damag
inflamm
sever
cytokin
chemokin
shape
magnitud
qualiti
immun
respons
occur
lung
specif
chemokin
regul
j
u
r
n
l
p
r
e
p
r
f
cellular
composit
mucos
tissu
induc
migrat
leukocyt
nonimmun
cell
express
cognat
receptor
twenti
three
chemokin
receptor
subset
identifi
human
broadli
classifi
atyp
chemokin
receptor
g
proteincoupl
chemotact
chemokin
receptor
n
although
certain
chemokinereceptor
pair
highli
specif
uniqu
often
sever
chemokinereceptor
pair
form
one
variabl
specif
depend
cellular
target
induc
migrat
depend
differenti
receptor
express
usag
well
potenti
agon
antagon
initi
chemokinereceptor
bind
function
observ
vivo
chemokin
act
g
proteincoupl
receptor
gpr
might
vari
bind
chemokin
receptor
trigger
chain
molecular
event
includ
dissoci
gtpbound
subunit
heterodim
initi
calcium
releas
endoplasmicreticulum
reservoir
activ
calciumdepend
signal
event
lead
downstream
initi
jakstat
mitogenactiv
protein
kinas
mapk
pathway
eventu
govern
function
respons
induc
chemokin
chemokin
rel
small
molecul
classifi
four
subfamili
accord
number
amino
acid
repres
x
locat
two
conserv
cystein
c
aminotermin
domain
cxc
cc
xc
member
cxc
famili
subdivid
base
presenc
absenc
triad
glutam
acidleucinearginin
elr
preced
cxc
sequenc
elrposit
elrneg
besid
structur
classif
chemokin
also
group
homeostat
inflammatori
base
physiolog
properti
addit
third
group
dual
chemokin
recogn
j
u
r
n
l
p
r
e
p
r
f
includ
overlap
function
chemokin
function
design
one
abovement
categori
chemokin
yet
assign
specif
function
role
beyond
immunolog
function
chemokin
display
biolog
properti
induct
stem
cell
mobil
promot
cellular
growth
angiogenesi
bactericid
activ
chemokin
activ
monomer
form
also
form
homoor
heterodim
one
chemokin
speci
result
chemokinereceptor
interactom
form
play
pivot
role
process
like
embryogenesi
wound
heal
vascular
pathogen
clearanc
benefici
host
howev
chemokin
also
particip
patholog
mechan
drive
autoimmun
chronic
inflamm
cancer
inde
increas
evid
implic
clinic
relev
pulmonari
disord
henc
mediat
repres
promis
new
target
translat
research
could
manipul
block
chemokinereceptor
axe
implic
patholog
condit
har
order
promot
benefici
chemokinemedi
mechan
despit
remark
advanc
gap
understand
chemokinereceptor
network
delay
therapeut
use
human
especi
chemokin
recent
discov
whose
function
fulli
character
myeloid
cellattract
chemokin
also
known
dendrit
cell
monocytelik
protein
dmc
vegf
coregul
chemokin
newest
member
cxcl
famili
chemotact
cytokin
describ
far
produc
along
airway
steadi
state
induc
inflammatori
condit
suggest
role
local
j
u
r
n
l
p
r
e
p
r
f
immun
respons
respiratori
system
current
attempt
character
biolog
reveal
involv
mainten
homeostasi
cellular
composit
differ
epitheli
surfac
moreov
recent
studi
show
involv
sever
human
health
diseas
play
either
protect
patholog
role
respect
thu
review
provid
overview
discoveri
characterist
function
specif
discuss
translat
potenti
diagnost
biomark
therapeut
agent
pulmonari
medicin
gene
first
describ
research
secret
protein
discoveri
initi
spdi
amino
acid
sequencebas
comparison
reveal
similar
structur
analysi
show
fold
similar
adopt
mutant
cxc
chemokin
core
togeth
find
suggest
identifi
protein
chemokin
cxcligand
chemokin
famili
gene
locat
compos
four
exon
code
amino
acid
propeptid
molecular
weight
human
mice
mous
human
immatur
version
share
amino
acid
sequenc
ident
moreov
pattern
express
similar
mucos
tissu
human
murin
speci
precursor
protein
six
cystein
residu
leu
leu
four
locat
among
phe
leu
particip
build
cxc
motif
posttransl
cleavag
remov
amino
acid
sequenc
contain
two
cystein
residu
aminotermin
domain
result
matur
protein
j
u
r
n
l
p
r
e
p
r
f
human
mice
matur
process
lead
attain
full
function
capac
fourcystein
matur
peptid
twofold
increas
chemoattract
activ
recruit
human
monocyt
mous
macrophag
vitro
compar
sixcystein
propeptid
therefor
aminotermin
sequenc
may
affect
affin
receptor
bind
process
although
function
cleav
fraction
remain
elucid
ident
receptor
somewhat
controversi
chemokin
affin
far
describ
induc
dosedepend
calcium
flux
pro
bcell
line
cell
transfect
howev
silenc
antagon
inhibit
migrat
primari
human
monocyt
respons
gradient
find
suggest
lack
select
ligand
therebi
exclud
sole
respons
activ
rais
possibl
presenc
anoth
yet
unidentifi
receptor
despit
establish
cell
migrat
inhibit
pertussi
toxin
ptx
reduc
affin
agonist
via
adp
ribosyl
heterotrimer
protein
result
uncoupl
gpcr
g
protein
furthermor
evid
show
intracellular
signal
trigger
attach
receptor
involv
second
messeng
cyclic
adenosin
monophosph
camp
activ
extracellular
signalregul
kinas
mapk
pathway
therefor
publish
studi
support
fact
receptor
gpcr
seven
transmembran
domain
express
respiratori
gastrointestin
tract
express
healthi
human
tissu
cell
line
show
basal
product
fetal
lung
sampl
well
adult
trachea
epithelium
bronchi
bronchiol
alveolar
cell
also
express
detect
stomach
small
intestin
colon
specif
within
line
epithelium
lumin
surfac
epitheli
cell
suggest
activ
process
secret
chemokin
airway
intestin
lumen
respect
interestingli
distribut
almost
restrict
epitheli
barrier
cover
lumen
sever
hollow
organ
secretori
conduct
contrast
mucos
chemokin
also
found
within
solid
parenchyma
differ
tissu
steadi
state
notabl
lung
airway
also
show
signific
express
variou
speci
mammal
includ
human
cattl
sheep
mice
rat
thu
support
potenti
role
chemokin
physiolog
respiratori
epithelium
tissu
express
profil
human
murin
speci
previous
describ
summar
tabl
known
induc
migrat
monocyt
dendrit
cell
dc
macrophag
via
jnk
signal
although
chemotact
effect
apc
differ
strength
apc
subset
instanc
matur
j
u
r
n
l
p
r
e
p
r
f
immatur
dc
mobil
respons
weaker
compar
monocyt
also
mention
fourcystein
matur
version
higher
chemoattract
activ
human
monocyt
mous
macrophag
compar
sixcystein
propeptid
thu
due
steadi
state
express
mucosa
endotheli
cell
respiratori
gastrointestin
tract
like
facilit
infiltr
apc
epitheli
barrier
cell
play
import
function
sens
antigen
composit
lumin
environ
inde
mice
exhibit
slight
decreas
number
alveolar
macrophag
normal
number
lung
interstiti
macrophag
differ
cellular
subset
tissu
cell
may
amplifi
signal
epithelium
endotheli
cell
also
produc
suggest
chemokin
facilit
exit
apc
vasculatur
inde
pretreat
monocyt
dc
enhanc
abil
attach
intracellular
adhes
molecul
also
known
integrin
bind
protein
relev
leukocyt
traffic
across
endothelium
interest
note
chemoattract
properti
restrict
apc
lymphocyt
thu
specif
impact
innat
immun
respons
adapt
immun
might
suggest
differenti
role
chemokin
infecti
metabol
diseas
angiogen
activ
cxc
chemokin
depend
presenc
absenc
elr
motif
although
elr
motif
describ
function
behav
member
group
angiogen
factor
fact
sever
human
endotheli
cell
line
human
microvascular
endotheli
cell
hmvec
sephranos
vascular
endotheli
cell
spvec
human
umbil
vascular
endotheli
cell
huvec
express
higher
level
prolifer
tube
format
huvec
cell
transfect
increas
express
gene
involv
angiogenesi
vascular
endotheli
growth
factor
vegfa
basic
fibroblast
growth
factor
bfgf
urokinasetyp
plasminogen
activ
upa
upa
receptor
upar
also
treatment
monocyt
matur
enhanc
abil
produc
vegfa
addit
express
coregul
proangiogen
molecul
vegf
sampl
lung
breast
esophag
cancer
final
one
import
gene
mutat
within
specif
genet
loci
stroke
suscept
strokepron
spontan
hypertens
rat
murin
model
spontan
cerebr
hemorrhag
suggest
potenti
particip
chemokin
mainten
vascular
structur
similar
mucosalassoci
also
exhibit
broad
spectrum
antimicrobi
activ
dose
depend
manner
escherichia
coli
staphylococcu
aureu
salmonella
sp
pseudomona
aeruginosa
candida
albican
interestingli
kill
known
probiot
lactobacillu
casei
downregul
proinflammatori
respons
elicit
pathogen
bacteria
like
ecoli
j
u
r
n
l
p
r
e
p
r
f
indic
select
benefici
natur
chemokin
potenti
shape
factor
microbiom
kill
activ
mucos
chemokin
retain
within
carboxyltermin
domain
aminotermin
respect
yet
discov
possibl
mechan
underli
bactericid
effect
associ
membran
permeabil
shown
assay
use
e
coli
cell
exposur
chemokin
result
hydrolysi
extracellular
nitrophenylbdgalactopyranois
onpg
cytoplasm
bgalactosidas
membran
permeabil
effect
akin
amp
granulysin
permeabil
cholesterol
free
microbi
membran
larg
ineffect
intracellular
pathogen
therefor
target
studi
defin
peptid
sequenc
determin
bactericid
featur
would
pave
way
complet
character
novel
chemokin
enabl
optimum
assess
potenti
therapeut
target
multifacet
biolog
activ
exhibit
shown
figur
consid
dual
chemokin
due
high
level
basal
express
well
induc
express
disrupt
homeostasi
although
exposur
commens
pathogen
microorgan
differ
mucos
surfac
trigger
product
level
induc
commens
microorgan
much
lower
comparison
induc
pathogen
microorgan
herp
simplex
viru
hsv
phenomenon
j
u
r
n
l
p
r
e
p
r
f
mainli
observ
lung
stomach
mucos
surfac
suggest
potenti
import
chemokin
interact
mucos
defens
respiratoryintestin
microbiom
well
respons
infecti
aggress
product
potenti
proinflammatori
signal
provid
cytokin
treatment
hacat
cell
normal
human
epiderm
keratinocyt
nhek
shown
increas
product
dosedepend
manner
increas
also
observ
primari
gastric
cell
respons
lipopolysaccharid
lp
alcohol
confirm
proinflammatori
signal
induc
product
demonstr
cell
type
may
also
becom
reservoir
protein
certain
inflammatori
condit
cellular
subset
receptor
signal
agent
respons
exacerb
product
mucos
surfac
yet
fulli
understood
howev
evid
posttranscript
regul
express
recent
data
indic
target
region
utr
gene
contain
sequenc
match
sequenc
inde
transfect
human
bronchial
cell
mirna
suppress
express
observ
shed
light
regulatori
mechan
product
specif
lung
airway
j
u
r
n
l
p
r
e
p
r
f
due
signific
vivo
physiolog
role
homeostasi
pathogenesi
consid
princip
player
differ
diseas
disord
interestingli
express
also
increas
skin
patholog
condit
psoriasi
fact
express
report
increas
skin
specimen
human
psoriasi
mice
imiquimodinduc
psoriasislik
skin
inflamm
wherein
epiderm
keratinocyt
main
sourc
product
recent
commun
also
report
higher
level
saliva
lacrim
fluid
patient
affect
syndrom
although
correl
diseas
sever
despit
data
pathogen
regulatori
natur
product
inflammatori
set
clear
current
concis
bodi
evid
suggest
antiinflammatori
mediat
condit
experiment
psoriasi
mice
autoimmun
diseas
respiratori
afflict
human
inde
mice
experiment
psoriasi
local
administr
relat
reduc
infiltr
lymphocyt
neutrophil
skin
reduc
cell
respons
well
lower
local
level
increas
express
chang
also
associ
recruit
myeloidderiv
stem
cell
mdsc
site
exposur
subsequ
attract
regulatori
treg
cell
way
moreov
vitro
assay
shown
treatment
also
attenu
lpsinduc
product
inflammatori
cytokin
nitric
oxid
macrophag
final
genet
knockdown
mice
recent
associ
increas
suscept
autoimmun
model
experiment
autoimmun
encephalomyel
eae
suggest
defici
signal
import
develop
mainten
autotoler
collect
data
strengthen
notion
potent
antiinflammatori
role
autoimmun
diseas
chemokinereceptor
axe
known
mediat
protect
suscept
microorgan
via
antibacteri
activ
recruit
leukocyt
promot
pathogen
dissemin
respect
context
role
immun
infect
remain
investig
recent
observ
express
highli
increas
duodenum
human
acut
cholera
natur
contribut
defens
vibrio
cholera
undetermin
likewis
mous
model
infect
inocul
viru
enhanc
product
vagin
mucosa
mice
concurr
mice
defici
suscept
could
control
viral
replic
viru
dissemin
dorsal
ganglia
diseas
phenotyp
associ
decreas
proport
antigenspecif
memori
cell
within
vagin
tissu
anim
broadspectrum
bactericid
activ
bacteria
associ
respiratori
infect
indic
involv
chemokin
lung
defens
howev
bacteri
diseas
tuberculosi
tb
gene
express
upregul
among
cell
isol
lung
tissu
patient
activ
diseas
suggest
chemokin
may
particip
earli
recruit
myeloid
cell
lung
parenchyma
mtb
infect
togeth
observ
stress
dual
role
play
chemokin
infecti
diseas
j
u
r
n
l
p
r
e
p
r
f
emerg
evid
support
dual
role
cancer
see
figur
sever
research
group
demonstr
increas
express
human
tissu
sampl
cell
line
breast
colon
gastric
pancreat
bladder
renal
uterin
cervic
human
hepatocellular
carcinoma
hhc
nonsmal
cell
lung
cancer
nsclc
enhanc
express
also
associ
abund
surround
peritumor
tissu
link
poor
surviv
recurr
patient
hcc
breast
cancer
function
mechan
underli
tumorigen
potenti
could
due
increas
cellular
prolifer
overexpress
normal
embryon
mous
fibroblast
cell
line
lead
gener
tumor
immunodefici
mice
also
hhc
cell
line
cell
well
breast
cancer
cell
line
transfect
plasmid
carri
increas
abil
prolifer
vitro
form
larger
tumor
vivo
may
also
protect
cancer
cell
apoptosi
instanc
hhc
cell
line
transfect
mild
degre
resist
cisplatininduc
apoptosi
addit
inhibit
autophagi
limit
activ
ampactiv
protein
kinas
ampk
pathway
recent
studi
shown
express
tumor
sampl
correl
presenc
marker
cell
prolifer
import
j
u
r
n
l
p
r
e
p
r
f
apoptot
pathway
potenti
drive
forc
tumorigen
effect
gain
import
anoth
featur
associ
tumorigen
potenti
mayb
abil
promot
metastasi
describ
hhc
cell
line
breast
cancer
cell
transfect
propos
chemokin
mechan
mediat
metastasi
may
relat
aberr
express
chemokin
receptor
lead
malign
cell
migrat
direct
chemotact
gradient
hypothesi
partial
support
observ
increas
express
breast
cancer
clinic
sampl
also
mrna
express
higher
lymph
node
invad
metastat
colon
cancer
correl
poor
surviv
risk
recurr
treatment
anoth
critic
tumorigen
featur
due
role
angiogenesi
format
new
blood
vessel
within
tumor
pivot
event
support
nutrient
suppli
cancer
progress
better
access
blood
vessel
enabl
cancer
cell
metastas
coregul
vegf
clinic
sampl
individu
cancer
secondli
fibroblast
cell
line
colon
cancer
cell
line
express
form
tumor
increas
vasculatur
abund
blood
suppli
inject
immunodefici
mice
tumor
character
infiltr
cell
migrat
respons
gradient
particip
promot
tumor
format
vascular
therefor
data
suggest
may
promot
tumor
final
may
also
modifi
immun
microenviron
tumor
instanc
tissu
sampl
human
hcc
colon
cancer
high
express
associ
presenc
cell
proport
correl
surviv
also
known
recruit
mdsc
treg
cell
alreadi
establish
mdsc
synerg
treg
cell
prevent
tumor
immun
promot
tumor
progress
contrast
current
insuffici
evid
support
role
antitumor
immun
respons
interestingli
mediat
infiltr
immatur
myeloid
dc
pancreat
intraduct
papillari
mucin
carcinoma
promot
render
tumor
suscept
cytotox
cell
mediat
cytolysi
also
express
lost
progress
pancreat
tumor
becom
malign
support
protect
effect
earli
stage
pancreat
cancer
develop
howev
whether
antitumor
role
would
extend
cancer
subtyp
would
necessari
avenu
futur
research
increas
concentr
report
bronchoalveolar
lavag
bal
sampl
patient
interstiti
pulmonari
fibrosi
ipf
suggest
chemokin
may
activ
particip
pathogenesi
diseas
although
exact
mechan
remain
unclear
like
recruit
inflammatori
immun
cell
result
profibrot
cytokin
secret
vascular
remodel
lead
lung
fibrosi
could
involv
although
specif
role
vascular
remodel
ipf
pathophysiolog
yet
controversi
certain
angiogen
cxc
chemokin
increas
ipf
patient
fact
certain
angiogen
cxc
chemokin
increas
ipf
patient
togeth
may
promot
excess
vascular
associ
deposit
fibrot
tissu
howev
hypothesi
experiment
test
mous
model
human
sampl
ipf
patient
final
chemokin
known
role
ipf
promot
recruit
fibroblast
lung
lead
increas
product
extracellular
matrix
although
current
evid
chemotact
activ
fibroblast
precursor
possibl
could
support
local
prolifer
lung
fibroblast
howev
line
reason
also
question
although
transfect
gene
embryon
mous
fibroblast
cell
line
promot
format
tumor
mediat
improv
prolif
capac
fibroblast
nevertheless
investig
potenti
induct
cell
prolifer
mediat
need
perform
use
human
primari
lung
fibroblast
human
lung
fibroblast
cell
line
definit
rule
mechan
subsequ
studi
confirm
role
pathogenesi
ipf
chemokin
would
constitut
novel
target
focu
develop
novel
therapeut
approach
devast
diseas
recent
particip
regul
eosinophil
inflamm
respons
type
asthma
establish
assess
express
bronchial
brush
sampl
asthmat
patient
show
higher
transcript
chemokin
compar
healthi
control
increas
express
restrict
bronchial
epithelium
furthermor
mechan
evalu
vitro
bronchial
cell
line
wherein
overexpress
gene
inhibit
product
epitheli
periostin
postn
molecul
involv
recruit
eosinophil
respons
exogen
stimul
also
invers
correl
transcript
level
observ
overregul
increas
product
postn
well
lung
eosinophil
inflamm
suppress
express
suggest
antiinflammatori
role
asthma
key
player
eosinophil
recruit
prolifer
airway
remodel
asthma
particip
airway
epitheli
cell
injuri
via
thu
enhanc
product
respiratori
epithelium
asthmat
individu
might
reflect
compensatori
effort
counteract
inflamm
airway
make
chemokin
potenti
target
immunotherapeut
develop
nonetheless
also
possibl
mediat
contrast
role
differ
stage
asthma
notion
evalu
futur
investig
addit
featur
increas
asthmat
individu
make
potenti
diagnost
biomark
target
studi
valid
yet
conduct
final
find
describ
prompt
clinic
research
look
potenti
role
allerg
respiratori
diseas
rhiniti
well
pulmonari
disord
caus
alter
infiltr
eosinophil
case
eosinophil
interstiti
lung
diseas
key
chemotact
factor
lung
macrophag
sentinel
cell
partak
defens
infecti
assault
normal
lung
condit
associ
chronic
inflamm
possibl
potenti
role
chemokin
respiratori
infect
warrant
inde
along
chemokin
found
highli
express
human
bronchial
epitheli
human
tracheobronchi
epitheli
cell
infect
influenza
viru
reduc
cell
infect
strain
avian
influenza
strain
virul
due
acquir
genet
properti
contribut
faster
replic
rate
rate
infect
compar
season
influenza
strain
data
studi
indic
express
significantli
upregul
cell
infect
attenu
mutant
strain
icsar
comparison
virul
wt
sarscov
strain
indic
virul
strain
intact
methyltransferas
mayb
avoid
induct
strong
innat
immun
respons
host
cell
collect
interest
note
studi
list
abil
induc
express
invers
relat
virul
viral
strain
indic
potenti
protect
influenc
respons
influenza
sarscov
infect
although
current
studi
assess
potenti
impact
chemokin
context
novel
caus
agent
ongo
pandem
anticip
futur
research
would
direct
toward
deciph
thu
pave
way
toward
identif
potenti
therapeut
target
virus
lung
cancer
lead
list
killer
neoplasia
worldwid
current
urgent
necess
identifi
novel
molecul
implic
cancer
biolog
fulfil
role
biomark
therapeut
target
stop
burden
caus
differ
histolog
subtyp
lung
cancer
regard
fact
express
observ
human
tissu
sampl
j
u
r
n
l
p
r
e
p
r
f
patient
nsclc
arous
interest
explor
possibl
particip
chemokin
molecular
pathogenesi
lung
cancer
studi
compar
concentr
biolog
sampl
bal
bronchial
brush
sputum
biopsi
specimen
plasma
human
lung
cancer
healthi
control
would
need
next
investig
look
correl
level
chemokin
clinic
paramet
risk
mortal
recurr
treatment
incid
metastasi
reveal
proor
antitumorigen
featur
activ
context
lung
cancer
furthermor
anim
model
use
knockout
mice
well
genet
manipul
express
lung
cancer
cell
line
reveal
underli
mechan
includ
promot
cellular
prolifer
escap
apoptosi
metastasi
regul
antitumor
immun
respons
support
angiogenesi
latter
mechan
may
deserv
particular
consider
sinc
angiogen
pathway
play
remark
role
promot
tumor
growth
nsclc
current
treatment
antiangiogen
factor
bevacizumab
inhibitor
vegf
main
strategi
manag
advanc
nsclc
howev
resist
bevacizumab
may
appear
patient
due
activ
angiogen
pathway
differ
vegf
signal
compensatori
mechan
includ
fgf
signal
proangiogen
factor
regul
therefor
target
could
good
strategi
improv
efficaci
antivegf
agent
lung
cancer
bacteri
pneumonia
one
main
caus
morbid
around
world
rise
preval
drug
resist
bacteria
contribut
morbid
mortal
infecti
lung
diseas
antimicrobi
peptid
amp
gain
attent
potenti
therapeut
agent
j
u
r
n
l
p
r
e
p
r
f
sinc
possess
broad
spectrum
activ
less
risk
resist
develop
investig
deliv
molecul
antimicrobi
activ
directli
respiratori
tract
potent
bactericid
activ
bacteri
strain
caus
respiratori
infect
tend
develop
resist
antibiot
staphylococcu
aureu
pseudomona
aeruginosa
therefor
may
repres
novel
candid
therapeut
approach
nonetheless
demonstr
bactericid
activ
chemokin
vivo
necessari
moreov
complet
character
structur
basi
antimicrobi
properti
requir
isol
peptid
sequenc
respons
activ
limit
collater
damag
result
excess
signal
role
sever
diseas
continu
explor
potenti
target
immunotherapi
envisag
although
consider
progress
made
understand
biolog
still
sever
knowledg
gap
could
pursu
research
gain
knowledg
role
health
disord
one
area
prioriti
identifi
gpcr
mediat
signal
aid
dissip
current
controversi
regard
potenti
implic
axe
pathogenesi
sever
human
diseas
key
particip
maintain
homeostasi
respiratori
epithelium
target
repres
interest
approach
develop
novel
therapeut
diagnost
respiratori
diseas
literatur
curat
hypothes
gener
review
provid
theoret
framework
help
futur
investig
aim
explor
multitud
potenti
clinic
applic
current
studi
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
jcp
st
particip
intellectu
concept
studi
draft
manuscript
jz
sak
design
studi
contribut
write
process
manuscript
revis
intellectu
content
author
read
approv
final
version
manuscript
current
studi
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
